Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'
- PMID: 33542103
- DOI: 10.1136/annrheumdis-2020-219312
Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'
Keywords: glucocorticoids; rituximab; systemic vasculitis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'' by Parikh et al.Ann Rheum Dis. 2023 Jan;82(1):e24. doi: 10.1136/annrheumdis-2020-219329. Epub 2021 Feb 4. Ann Rheum Dis. 2023. PMID: 33542105 No abstract available.
Comment on
-
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.Ann Rheum Dis. 2020 Sep;79(9):1243-1249. doi: 10.1136/annrheumdis-2019-216863. Epub 2020 Jun 24. Ann Rheum Dis. 2020. PMID: 32581088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
